Open AccessFatal Mucormycosis Post COVID-19 Infection in Uncontrolled Diabetes with Misuse of Glucocorticoids and Antibiotics
Author(s) -
Heba S. Hamed,
Raed Madia,
Hosniyeh Ladadweh,
Hiba Falana,
Abdallah Damin Abukhalil
Publication year - 2022
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s356465
Subject(s) - mucormycosis , covid-19 , medicine , antibiotics , diabetes mellitus , intensive care medicine , virology , microbiology and biotechnology , biology , endocrinology , infectious disease (medical specialty) , surgery , outbreak , disease
Mucormycosis is a fulminant and rapidly progressing fungal infection associated with a high mortality rate. Mucormycosis is primarily seen in immunocompromised patients, especially those with uncontrolled diabetes mellitus (DM), and recently in coronavirus disease 2019 (COVID-19) patients.